Position in NVO
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$447,424
+$101,680 QoQ
Shares Held
9,333
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#749
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cairn Investment Group, Inc. holds $15,565,541 across 7 Drug Manufacturers - General names. NVO ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
54,875 | $7,051,437 | |
| 2 | LLY |
ELI LILLY & Co
|
2,610 | $3,130,512 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
21,247 | $2,684,345 | |
| 4 | BIIB |
Biogen Inc.
|
8,043 | $1,737,770 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
9,333 | $447,424 | |
| 6 | JNJ |
Johnson & Johnson
|
1,060 | $269,208 | |
| 7 | ABBV |
AbbVie Inc.
|
973 | $244,845 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $447,424 | 9,333 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $345,744 | 9,408 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $525,488 | 10,328 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $573,100 | 10,328 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $712,838 | 10,328 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $686,206 | 9,882 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $864,501 | 10,050 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,232,562 | 18,750 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,704,923 | 18,950 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,458,860 | 19,150 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,984,171 | 19,180 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,748,776 | 19,230 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,564,086 | 9,665 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,547,636 | 9,725 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,466,571 | 18,225 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $1,789,852 | 17,965 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,072,598 | 18,600 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $3,006,123 | 27,070 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $3,031,840 | 27,070 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,634,994 | 27,445 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,328,387 | 27,795 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,873,938 | 27,795 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,954,403 | 27,980 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,706,381 | 38,980 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $2,692,865 | 41,125 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $2,583,784 | 42,920 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||